AIHTA - Publications - Search - Trastuzumab deruxtecan (Enhertu®) in patients with previously treated HER2-positive breast cancer

Grössmann, N. (2020): Trastuzumab deruxtecan (Enhertu®) in patients with previously treated HER2-positive breast cancer. Oncology Fact Sheet Nr. 32.

[thumbnail of Oncology Fact Sheet Nr.32.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
68kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WP Gynaecology > WP 800-910 Breast
Language:English
Series Name:Oncology Fact Sheet Nr. 32
Deposited on:04 Jan 2021 14:11
Last Modified:04 Jan 2021 16:34

Repository Staff Only: item control page